NeuroRisk.aiRequest Access →
drug · Product Intelligence

Florbetapir F 18
Pipeline Intelligence

Florbetapir F 18: 9 indexed trials, 2 sponsors; 2 linked Orange Book patents and 1 FDA-linked events where matched.

Request product intelligence brief →
⚗
9Indexed trials
▦
2Sponsors
⌁
2Orange Book patent links
◎
1FDA-linked events

Development evidence

NCT00702143Avid Radiopharmaceuticals · alzheimersPHASE2
NCT00857415Avid Radiopharmaceuticals · alzheimersPHASE3
NCT00857506Avid Radiopharmaceuticals · alzheimersPHASE2
NCT00857532Avid Radiopharmaceuticals · parkinsonsPHASE2
NCT01518374Avid Radiopharmaceuticals · alzheimersPHASE2
NCT01550549Avid Radiopharmaceuticals · alzheimersNA
NCT01565330Avid Radiopharmaceuticals · alzheimersPHASE1
NCT02016560Avid Radiopharmaceuticals · alzheimersPHASE2, PHASE3
NCT02667496Sanofi · alzheimersPHASE2

FDA / patent evidence

7687052AMYVID · app 2020082027-04-30
8506929AMYVID · app 2020082027-04-30

Regulatory context

FDA_APPROVALAMYVID · 2023-10-13

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.